I'm bringing this to this subs attention, because I feel it can offer huge gains in a short period. Delete if need be.

Top line data is due end of year for their drub cosibelimab. Previous results have been very positive and all signs point to positive data any day now. Drug has far less side effects and a cheaper price point than current drugs on the market. Checkpoint will be entering a 25B market with this drugs. I believe they have five more drugs currently in testing. Analyst average price for the stock is 15.00 and it sits at 3.00 now.

I currently have 25k shares and 150 open contracts. Mix of 2.5 and 5 for January and a 30 I think in April.